customerservice@curanthealth.com
866-460-8040

Curant Newsroom

Asembia 2018 Insights: consolidation madness, carrots and sticks

May 21, 2018 – Curant Health COO, Marc O'Connor, in PharmExec.com: A mad dash to consolidation is sweeping the healthcare industry. It appears that all stakeholders are bulking up and that vertical integration is the new key to long-term viability. Questions about the future direction of Amazon, JPMorgan, Berkshire Hathaway, Walmart, and Humana—along with their […]

Read More
Chattanooga CARES HIV patients achieve record medication adherence levels, 90.5%, with care management support from Curant Health

April 25, 2018 (Atlanta, GA) - “For the first time I am now positive about my future living with HIV.” – Chattanooga CARES patient Charlie An estimated $300 billion is wasted in U.S. healthcare spending every year due to medication non-adherence. Studies also verify 30 percent of prescriptions never get filled and 50 percent of […]

Read More
Access Headwinds Reach IDN Specialty Pharmacy Programs

April 27, 2018 – Curant Health COO, Marc O'Connor, in PharmExec.com: This year’s IDN Biopharma Strategy Summit from CBI was a useful, intimate gathering of roughly 100 industry leaders, approximately 25% of which represented IDNs, 70% pharmaceutical manufacturers, and 5% various service providers. Confirmed: it's tough going for IDNs that want to set up their […]

Read More
Improving Persistence: Brand Team Dos and Don'ts

April 10, 2018 – Curant Health Senior Director of Commercial Strategy & Performance, Jake Caines, in PharmExec.com. If persistence is the gold standard by which brand teams measure success investing the right amount of time in the right type of resources is critical. In part 4 of this 4-part series, we will discuss tactics brand teams […]

Read More
Managed Healthcare Executive: HIV treatment pipeline prospects getting healthier

Curant Health Director of Clinical Services Vickie Andros shares her HIV therapy insights with Managed Healthcare Executive   Advancements in HIV treatment over the past 20 years or so have been absolutely remarkable. When demonstrating excellent adherence to medication therapy, people living with HIV are managing it like a common, chronic condition experiencing increasing longevity […]

Read More
Top barriers to patient persistence

[et_pb_section fb_built="1" _builder_version="3.22"][et_pb_row _builder_version="3.25" background_size="initial" background_position="top_left" background_repeat="repeat"][et_pb_column type="4_4" _builder_version="3.25" custom_padding="|||" custom_padding__hover="|||"][et_pb_text _builder_version="4.4.1" background_size="initial" background_position="top_left" background_repeat="repeat" hover_enabled="0"] Physician time constraints, competing priorities for patients and shortcomings in follow-up initiatives are a few of the top causes of medication non-adherence; a $300 billion source of wasted U.S. healthcare spending every year. What can pharma brand teams do […]

Read More
Pharma: Meet Your New Neighbors

Executives from patient care, diagnostics, payer and pharma companies converge to share the inside scoop on outcomes-based contracting Curant Health's COO, Marc O'Connor, recently participated on a panel held at the CBI Outcomes-Based Contracting conference in Philadelphia. Marc was joined on the panel by speakers Harry Vargo of Aetna and Sachin Kamal-Bahl of Pfizer, along […]

Read More
Removing Barriers and Finding Solutions for Non-adherent HIV-Positive Patients: A Care Management Patient Success Story

Curant Health has partnered with Chattanooga Cares to offer a highly coordinated program of clinical services, reporting, and analytics.

Read More
Insights From A Bustling 340B Winter Conference

This year’s 340B Winter Conference was bursting at the seams with attendees. There were over 1,630 registrants for the conference representing a 12% growth over last year’s numbers. It was standing room only in the “340B Lessons from the Field” sessions led by many of our covered entity partners. In fact, there is so much […]

Read More
What does it take to improve outcomes advocacy? Introducing the PEER Model

Once a prescription is written - just one part of the brand adoption challenge - pharmaceutical manufacturers are limited in their ability to influence patient compliance and persistence. For years, pharma manufacturers have struggled to influence change in the 20-30 percent of prescriptions that never get filled and the estimated 50 percent of patients who […]

Read More

phone

866-460-8040

Headquarters

200 Technology Ct., Suite B
Smyrna, GA 30082

E-mail

customerservice

@curanthealth.com
homeenvelopephonemenu-circlecross-circle linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram